Detalles de la búsqueda
1.
Evolution of cisplatin resistance through coordinated metabolic reprogramming of the cellular reductive state.
Br J Cancer
; 128(11): 2013-2024, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37012319
2.
Oropharyngeal cancer outcomes correlate with p16 status, multinucleation and immune infiltration.
Mod Pathol
; 35(8): 1045-1054, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35184149
3.
Gain-of-function mutant p53 promotes cell growth and cancer cell metabolism via inhibition of AMPK activation.
Mol Cell
; 54(6): 960-974, 2014 Jun 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-24857548
4.
Knowledge-based planning for the radiation therapy treatment plan quality assurance for patients with head and neck cancer.
J Appl Clin Med Phys
; 23(6): e13614, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35488508
5.
Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge" (December 4th-5th, 2019, Naples, Italy).
J Transl Med
; 19(1): 13, 2021 01 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33407605
6.
Late and Long-Term Treatment-Related Effects and Survivorship for Head and Neck Cancer Patients.
Curr Treat Options Oncol
; 21(12): 92, 2020 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33009956
7.
Radiographic retropharyngeal lymph node involvement in HPV-associated oropharyngeal carcinoma: Patterns of involvement and impact on patient outcomes.
Cancer
; 125(9): 1536-1546, 2019 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30620385
8.
Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy.
Cancer
; 125(11): 1823-1829, 2019 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30748005
9.
Outcomes of patients diagnosed with carcinoma metastatic to the neck from an unknown primary source and treated with intensity-modulated radiation therapy.
Cancer
; 124(7): 1415-1427, 2018 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29338089
10.
Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial.
Br J Cancer
; 118(3): 331-337, 2018 02 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29235564
11.
Actionable Locoregional Relapses after Therapy of Localized Esophageal Cancer: Insights from a Large Cohort.
Oncology
; 94(6): 345-353, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29705797
12.
Predicting treatment Response based on Dual assessment of magnetic resonance Imaging kinetics and Circulating Tumor cells in patients with Head and Neck cancer (PREDICT-HN): matching 'liquid biopsy' and quantitative tumor modeling.
BMC Cancer
; 18(1): 903, 2018 Sep 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-30231854
13.
Pathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival-The University of Texas MD Anderson Cancer Center experience.
Cancer
; 123(21): 4106-4113, 2017 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28885712
14.
Nuclear expression of Gli-1 is predictive of pathologic complete response to chemoradiation in trimodality treated oesophageal cancer patients.
Br J Cancer
; 117(5): 648-655, 2017 Aug 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-28728163
15.
101 Long-Term Survivors Who Had Metastatic Gastroesophageal Cancer and Received Local Consolidative Therapy.
Oncology
; 93(4): 243-248, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28683449
16.
Metastatic Gastroesophageal Adenocarcinoma Patients Treated with Systemic Therapy Followed by Consolidative Local Therapy: A Nomogram Associated with Long-Term Survivors.
Oncology
; 91(1): 55-60, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27120436
17.
A Nomogram to Predict Distant Metastases After Multimodality Therapy for Patients With Localized Esophageal Cancer.
J Natl Compr Canc Netw
; 14(2): 173-9, 2016 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-26850487
18.
Mining the past to treat the present, ever mindful of the future: Low-dose radiotherapy and COVID-19 pneumonia.
Cancer
; 126(23): 5017-5021, 2020 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32985700
19.
Pre-Radiation Therapy Fluorine 18 Fluorodeoxyglucose PET Helps Identify Patients with Esophageal Cancer at High Risk for Radiation Pneumonitis.
Radiology
; 275(3): 822-31, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25584706
20.
Geographic distribution of regional metastatic nodes affects the outcome of trimodality-eligible patients with esophageal adenocarcinoma.
Oncology
; 88(6): 332-6, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25765098